Drug recall · September 4, 2024
Ibuprofen Tablets recall
Why: Failed Impurities/Degradation Specifications - at 18-month Stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
- Lots / codes
Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.
- Quantity
- 266 bottles
- Company
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Distribution
- CA and NV
- Initiated
- August 8, 2024 · Voluntary: Firm initiated
- Classified
- August 26, 2024
- Reported
- September 4, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.